Manufacture of basic pharmaceutical products

NACE Rev. 2.1Class

Export JSON Export CSV Export Markdown Compare

Use exports when you need a reusable copy of this reference page.

What this code covers

Use this class for manufacture of basic pharmaceutical products when the main activity includes Manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids) and Processing of blood. Check exclusions and nearby codes before applying it to a mixed activity.

Official NACE Rev. 2.1 labels and explanatory notes are imported from the source dataset. Plain-language explanations are shown separately so readers can compare interpretation with the source text.

Official explanatory notes

Imported source text for this NACE Rev. 2.1 record.

This class includes: - manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids) - processing of blood

Hierarchy context

Where this code sits in the NACE Rev. 2.1 hierarchy.

Parent code

21.1Manufacture of basic pharmaceutical productsGroup

Child codes

0 children

No child codes; this is a class-level code.

When this code fits

Use this when the main activity matches these signals.

manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids)
processing of blood
manufacture of chemically pure sugars
manufacture of probiotics

When to compare another code

Compare another code when these signals dominate.

manufacture of advance cell and gene therapy pharmaceutical preparations, see 21.20

Check before relying on this code

Situations where source text, close alternatives, or local rules may matter.

Compare with 21.20, 21.1 when the main activity overlaps another code.
Check national equivalent caveats before using this code for local registration or filing workflows.
If the main revenue activity appears in an exclusion, compare the alternative code before deciding.

Use this guide as classification support, not legal, tax, filing, or regulatory advice.

Inclusions

Signals that usually point toward this code.

- manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids)
- processing of blood
- manufacture of chemically pure sugars
- manufacture of probiotics
- processing of glands and manufacture of extracts of glands, etc.

Exclusions

Activities that should trigger comparison with another code.

- manufacture of advance cell and gene therapy pharmaceutical preparations, see 21.20

Examples

- Manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids)
- Processing of blood
- Manufacture of chemically pure sugars
- Manufacture of probiotics

Common mistakes

- Manufacture of advance cell and gene therapy pharmaceutical preparations

Search terms and quick answers

Plain-language discovery help for common business descriptions. These notes are separate from official source text.

Common search terms

Manufacture of basic pharmaceutical products21.10 Manufacture of basic pharmaceutical productsManufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids)Processing of bloodManufacture of chemically pure sugars

What is NACE 21.10 used for?

Use NACE 21.10 for manufacture of basic pharmaceutical products when the main activity matches this scope: Use this class for manufacture of basic pharmaceutical products when the main activity includes Manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids) and Processing of blood. Check exclusions and nearby codes before applying it to a mixed activity.

Based on: title and summary

What are typical examples for 21.10?

Typical examples include Manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids), Processing of blood, and Manufacture of chemically pure sugars.

Based on: examples

When might 21.10 not be the right code?

Review another code when the activity is closer to manufacture of advance cell and gene therapy pharmaceutical preparations, see 21.20.

Based on: exclusions and nonExamples

Which codes should I compare before choosing 21.10?

Compare 21.10 with 21.20 Manufacture of pharmaceutical preparations and 21.1 Manufacture of basic pharmaceutical products when the activity description is ambiguous.

Based on: relatedCodes and nearby codes

Often Confused With

Use these comparisons when the activity description is ambiguous.

21.20

Manufacture of pharmaceutical preparations

Use this class for manufacture of pharmaceutical preparations when the main activity includes Manufacture of medicaments: and Antisera and other blood fractions. Check exclusions and nearby codes before applying it to a mixed activity.

21.1

Manufacture of basic pharmaceutical products

Use this group for the broader activity area of manufacture of basic pharmaceutical products, including Manufacture of basic pharmaceutical products. Open the child codes when a more specific code is needed.

Compare these codes

Version changes

Plain-language Rev. 2 to Rev. 2.1 correspondence for this code.

Previous code

21.10

Rev. 2 code 21.10 maps to the same Rev. 2.1 class 21.10 Manufacture of basic pharmaceutical products.

exact

Official close match imported from NACE Rev. 2.1.

Potential impact

Low operational impact is expected, but systems should still store the target Rev. 2.1 version explicitly.

What to check next

Confirm the target version field and update references where Rev. 2.1 is required.

Open change record Convert this old code

What this code covers

Official NACE Rev. 2.1 labels and explanatory notes are imported from the source dataset. Plain-language explanations are shown separately so readers can compare interpretation with the source text.